We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
109 hedge funds and large institutions have $250M invested in Corcept Therapeutics in 2016 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 24 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
127% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 11
79% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 24
26% more capital invested
Capital invested by funds: $199M → $250M (+$50.9M)
14% more funds holding
Funds holding: 96 → 109 (+13)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
109
Holders Change
+13
Holders Change %
+13.54%
% of All Funds
2.91%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
25
Increased
43
Reduced
24
Closed
11
Calls
$360K
Puts
–
Net Calls
+$360K
Net Calls Change
+$201K
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$5.97M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
+$1.75M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.72M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.36M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.01M |
